The research progress in the biological treatment of intervertebral disc degeneration
10.3760/cma.j.cn121113-20220526-00301
- VernacularTitle:椎间盘退变的生物学治疗研究进展
- Author:
Xinjian KANG
1
;
Dawei ZHAO
;
Haiwei XU
;
Baoshan XU
Author Information
1. 天津医科大学研究生院，天津 300211
- Keywords:
Intervertebral disc degeneration;
Biological therapy;
Inflammation;
Cytoskeleton;
Biocompatible materials
- From:
Chinese Journal of Orthopaedics
2023;43(4):263-268
- CountryChina
- Language:Chinese
-
Abstract:
Intervertebral disc degeneration is the most common cause of chronic low back pain and the leading cause of disability in adults. The fact that lacking of effective treatment methods often causes a serious economic and social burden. Intervertebral disc degeneration is the result of multifactorial factors. The prevalence of intervertebral disc degeneration increases drastically with age, what is more, mechanical trauma, genetic predisposition,lifestyle factors and certain metabolic disorders. At present, the main treatment methods both pharmacological and surgical interventions just aim at relieving symptoms and improving function, and can not fundamentally reverse the process of intervertebral disc degeneration, which not only bring inevitable side effects and high cost, but also the long-term curative effect is limited. In theory, biological therapy can not only reverse or delay the process of it, but also can maximize preservation and restore the normal physiological function of the disc, which has been the focus and hot spot areas of research in recent years. The methods of inhibiting inflammation, promote the proliferation and division of residual cells, stem cell transplantation, cell scaffolds and new biomaterials all provide new ideas and direction for the treatment of intervertebral disc degeneration. This paper makes a review of the research progress in related fields, in order to provide a valuable reference for the selection of intervertebral disc degeneration treatment options.
